Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiety: Overview01:18

Anxiety: Overview

950
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
950
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

651
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
651
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

948
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
948
Social Anxiety Disorder01:28

Social Anxiety Disorder

458
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
458
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

19.4K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
19.4K
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

3.4K
Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FDA Decisions on Measures of Hypoactive Sexual Desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment.

Sexual medicine reviews·2021
Same author

Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.

The journal of sexual medicine·2019
Same author

Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?

The journal of sexual medicine·2019
Same author

Lumping, Splitting, and Treating: Therapies Are Needed for Women With Overlapping Sexual Dysfunctions.

Sexual medicine reviews·2019
Same author

Toward a Scientific Nutritional Supplement Combination for Prostatism and Erectile Dysfunction I: From Known Pharmacology to Clinical Testing.

Journal of medicinal food·2019
Same author

Trazodone in Sexual Medicine: Underused and Overdosed?

Sexual medicine reviews·2018

Related Experiment Video

Updated: Jan 20, 2026

Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

8.1K

Sexual Performance Anxiety.

Robert E Pyke1

  • 1Pykonsult, LLC, New Fairfield, CT.

Sexual Medicine Reviews
|August 27, 2019
PubMed
Summary

Sexual performance anxiety (SPA) affects millions, contributing to sexual dysfunction. While treatments like CBT and certain medications show promise, further research is needed for effective SPA management.

Area of Science:

  • Psychology
  • Pharmacology
  • Sexual Medicine

Background:

  • Sexual performance anxiety (SPA) is a widespread sexual complaint lacking a formal diagnosis, leading to limited research and treatment options.
  • SPA affects a significant portion of the population, with prevalence estimates ranging from 9-25% in men and 6-16% in women.

Purpose of the Study:

  • To review the prevalence of SPA and its association with sexual dysfunctions and anxiety disorders.
  • To compare SPA with non-sexual performance anxiety and social anxiety (PA/SA).
  • To explore potential pharmacological and phytotherapeutic treatments for SPA based on existing drug properties.

Main Methods:

  • Literature review of SPA and PA/SA using PubMed searches from 2000 to 2018.
  • Prevalence data sourced from population-representative surveys.
Keywords:
Anxiety DisordersErectile DysfunctionHypoactive Sexual Desire DisorderPremature EjaculationSexual Arousal DisorderSexual Performance Anxiety

More Related Videos

Hyponeophagia: A Measure of Anxiety in the Mouse
05:52

Hyponeophagia: A Measure of Anxiety in the Mouse

Published on: May 17, 2011

22.6K
Assessment of Sexual Behavior of Male Mice
04:38

Assessment of Sexual Behavior of Male Mice

Published on: March 5, 2020

21.8K

Related Experiment Videos

Last Updated: Jan 20, 2026

Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

8.1K
Hyponeophagia: A Measure of Anxiety in the Mouse
05:52

Hyponeophagia: A Measure of Anxiety in the Mouse

Published on: May 17, 2011

22.6K
Assessment of Sexual Behavior of Male Mice
04:38

Assessment of Sexual Behavior of Male Mice

Published on: March 5, 2020

21.8K
  • Prioritization of controlled clinical trials for treatment efficacy assessment.
  • Main Results:

    • SPA is linked to premature ejaculation and psychogenic erectile dysfunction (ED) in men, and severely inhibits sexual desire in women.
    • Cognitive behavior therapy (CBT) and mindfulness meditation are recommended for SPA, though controlled studies are limited.
    • Pharmacological options include PDE5 inhibitors for ED/PE, and serotonergic anxiolytics (e.g., buspirone, trazodone) with potential prosexual effects. Phytotherapies like sage and passionflower also show anxiolytic potential.

    Conclusions:

    • SPA significantly contributes to common sexual dysfunctions, yet well-established treatments are lacking.
    • Cognitive behavior therapy, mindfulness, and specific serotonergic anxiolytics show therapeutic potential for SPA.
    • Phosphodiesterase type 5 inhibitors are effective for SPA-related ED and premature ejaculation, with several phytotherapies also warranting further investigation.